# AmorChem

AmorChem is a Private Equity based in Montréal, Canada.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Montréal, Canada
- **Region:** North America
- **Address:** Westmount, Canada
- **Founded:** 2011
- **Assets under management:** $87M
- **Website:** www.amorchem.com
- **LinkedIn:** https://www.linkedin.com/company/amorchem-venture-fund

## Regulatory record

- **Reports private funds:** No

## About

AmorChem is a leading early stage venture fund dedicated to creating the next generation of biotech companies from academic research. Since 2011, it has financed over 30 research programs in academia and accelerated the creation of several biotech companies. It focuses on translational research to bridge the innovation gap from fundamental academic research into next generation biotech companies, and aims to be the premier early-stage venture fund in Canada.

## Sectors

- Biotech and therapeutic innovation from academic research

## People

- Dr. Kevin McBride — General Partner

## Questions

### How does AmorChem source its investment opportunities?

The firm's entire model relies on proximity to Canadian universities and research hospitals. It identifies licensable therapeutic programs inside academic labs that have strong intellectual-property positions but lack commercial infrastructure. Deals are sourced through ongoing relationships with technology-transfer offices and principal investigators, not through GP-led auctions or inbound broker decks.

### What investment stages does AmorChem target?

AmorChem concentrates on the gap between academic discovery and institutional venture capital — seed, start-up, and early-stage programs. The strategy also includes growth-position follow-ons and divestiture opportunities when a therapeutic asset requires a structured exit or a spin-off into a new entity. The firm does not operate a late-stage or pre-IPO vehicle.

### What is AmorChem's geographic focus?

Portfolio formation is anchored in Canadian academic centers, particularly in Quebec and Ontario. As companies mature and require syndicated US financing, AmorChem facilitates cross-border exposure, often bringing in Boston- or Bay Area-based venture partners for follow-on rounds.

## Related profiles

- [aMoon](https://altss.com/profile/amoon)
- [Amore Ambro](https://altss.com/profile/amore-ambro)

---

Updated: 2026-08-11T15:06:04.815Z

Canonical page: https://altss.com/profile/amorchem

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology